Sevasti Karaliota

机构：Leidos (United States), National Cancer Institute, Center for Cancer Research, Leidos Biomedical Research Inc. (United States) · ORCID：0000-0001-7226-8207

发表论文 40 篇 · 总被引 1040 次 · h-index 15

代表论文

• Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients (2021 · Cell Reports · 被引 241)
• Mapping metabolic changes by noninvasive, multiparametric, high-resolution imaging using endogenous contrast (2018 · Science Advances · 被引 188)
• SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors (2021 · European Journal of Internal Medicine · 被引 72)
• Anandamide Increases the Differentiation of Rat Adipocytes and Causes PPARγ and CB1 Receptor Upregulation (2009 · Obesity · 被引 72)
• CRH Promotes the Neurogenic Activity of Neural Stem Cells in the Adult Hippocampus (2019 · Cell Reports · 被引 58)
• Heterodimeric IL-15 in Cancer Immunotherapy (2021 · Cancers · 被引 52)